Evaluation of pertussis immunity status in schoolchildren immunized with whole-cell vaccine

Epidemiology and Infection

Volumn 138, Issue 2, 2010, Pages 299-303

  Duranoglu, L ^a   Snmez, C ^b   Vurucu, S ^a   Kurtoglu, D ^b   Kesik, V ^a   Coplu, N ^b   Koseoglu, V ^a   Esen, B ^a   Ozcan, O ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Refik Saydam Hygiene Center   (Turkey)

Author keywords

Anti pertussis toxin antibody; Children; Pertussis; Turkey; Vaccination

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PERTUSSIS TOXIN; PERTUSSIS VACCINE; UNCLASSIFIED DRUG; WHOLE CELL VACCINE; ANTITOXIN;

ADOLESCENT; AGE; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HIGH SCHOOL; HUMAN; IMMUNE STATUS; IMMUNIZATION; INCIDENCE; INCOME; MAJOR CLINICAL STUDY; MALE; PERTUSSIS; PRIMARY SCHOOL; SCHOOL CHILD; SOCIAL STATUS; TURKEY (REPUBLIC); AGE DISTRIBUTION; BLOOD; BORDETELLA PERTUSSIS; IMMUNOLOGY;

ADOLESCENT; AGE DISTRIBUTION; ANTIBODIES, BACTERIAL; ANTITOXINS; BORDETELLA PERTUSSIS; CHILD; FEMALE; HUMANS; MALE; PERTUSSIS VACCINE; WHOOPING COUGH;

EID: 74949143272     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S095026880999032X     Document Type: Article

References (25)

1. Yeh SH. Pertussis : persistent pathogen, imperfect vaccines. Expert Review of Vaccines 2003; 2: 113-127.
2. World Health Organization. Pertussis vaccines : WHO position paper. Weekly Epidemiological Record 1999; 74: 137-142.
3. Petersen JW. Cellular immunity in relation to pertussis vaccination and infection. Danish Medical Bulletin 1995; 42: 121-140.
4. Centers for Disease Control and Prevention. Notice to readers : final 2003 reports of notifiable diseases. Mortality and Morbidity Weekly Report 2004; 53: 687-691.
5. Levy-Bruhl D, et al. A comparison of vaccination programmes. Part two: pertussis. Eurosurveillance 1998; 3: 107-110.
6. Hutchins SS, et al. Current epidemiology of pertussis in the United States. Tokai Journal of Experimental and Clinical Medicine 1988; 13: 103-109.
7. World Health Organization. Pertussis surveillance, a global meeting, Geneva, 16-18 October 2000 (2001). Departments of Vaccines and Biologicals. Geneva: World Health Organisation. WHO/V&B/01.19.
8. Aksakal FN, et al. Pertussis incidence among school children with prolonged cough in Turkey: There is a need for booster vaccination policy. Tohoku Journal of Experimental Medicine 2007; 211: 353-358.
9. Vatansever U, et al. Seroprevalance of Bordetella pertussis antibodies among healthy adolescent girls in Edirne. Swiss Medical Weekly 2005; 135: 531-536.
10. Esen B, et al. Prevalence of high antibody titers of pertussis in Turkey; a reflection of circulating microorganism, which is a threat to infants. Journal of Clinical Laboratory Analysis 2007; 21: 154-161.
11. Greenberg DP. Pertussis in adolescents : increasing incidence brings attention to the need for booster immunization of adolescents. Pediatric Infectious Disease 2005; 24: 721-728.
12. Coplu N, et al. Standardization of an in-house ELISA for pertussis serology and its application in a seroepidemiological study. Microbiology Bulletin 2005; 39: 281-289.
13. De Melker HE, et al. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. Clinical Microbiology 2000; 38: 800-806.
14. Baughman AL, et al. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clinical and Diagnostic Laboratory Immunology 2004; 11: 1045-1053.
15. Konda T, et al. Distribution of pertussis antibodies among different age groups in Japanese Vaccine 2002; 20: 1711-1717.
16. Giammanco A, et al. European Sero-Epidemiology Network: standardization of the assay results for pertussis. Vaccine 2003; 22: 112-120.
17. Celentano LP, et al. Resurgence of pertussis in Europe. Pediatric Infectious Disease Journal 2005; 24: 761-765.
18. Skowronski DM, et al. The changing age and seasonal profile of pertussis in Canada. Journal of Infectious Disease 2002; 185: 1448-1453.
19. Turkish Foundation of Statistics. Data on Report 'Marriages in Turkey' (http://www.tuik.gov.tr/ PreIstatistikTablo.do?istab-id=756).
20. Elliott E, et al. National study of infants hospitalized with pertussis in the acellular vaccine era. Pediatric Infectious Disease Journal 2004; 23: 246-252.
21. Ntezayabo B, De Serres G, Duval B. Pertussis resurgence in Canada largely caused by a cohort effect. Pediatric Infectious Disease Journal 2003; 22: 22-27.
22. Ozkan A, Pekcan H. Investigation of the factors affecting the immunization status and immunity in 4 primary health center area of the city Diyarbakir. Epidemiology and Public Health Affiliation Postgraduate Thesis, 2003, pp. 121-124.
23. Giammanco A, et al. Seroepidemiology of pertussis in Italy. Review Infectious Disease 1991; 13: 1216-1220.
24. Plotkin SA. The effectiveness of whole-cell pertussis vaccines. Developments in Biological Standardization 1997; 89: 171-174.
25. Stroffolini T, et al. Seroepidemiology of pertussis infection in an urban childhood population in Cameroon. European Journal of Epidemiology 1991; 7: 64-67.